Vuno secures second 510(k) and more briefs
Vuno receives second 510(k) South Korean medical AI company Vuno has obtained a 510(k) clearance from the United States Food and Drug Administration for its chest X-ray analysis AI software. The VunoMed Chest X-ray Triage quickly screens for pneumothorax and... Read More →
Indapta Therapeutics applies TIMING to elucidate the mechanisms of enhanced ADCC featuring CellChorus®
HOUSTON, Texas — November 20, 2024. Indapta Therapeutics (Houston, TX & Seattle, WA) presented data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting featuring data from the CellChorus® Time-lapse Imaging Microscopy In Nanowell Grids™ (TIMING™) platform demonstrating that... Read More →
Enrich TROVO Recognized With BioTech Breakthrough’s “Cell Sorting Product of the Year”
Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industries LOS ANGELES, Nov. 19, 2024 (GLOBE NEWSWIRE) — BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products... Read More →
Zenflow Announces $24 Million Financing Round to Fund FDA Filing & Commercial Preparation
Round to Support PMA Submission of Minimally Invasive Treatment for Enlarged Prostate Symptoms SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged... Read More →
Healionics’ STARgraft Receives FDA Breakthrough Device Designation
SEATTLE, WA, UNITED STATES, November 14, 2024 /EINPresswire.com/ — Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced that its STARgraft arteriovenous graft – designed to provide a safer and more reliable means of bloodstream access for kidney... Read More →
myBiometry raises funding to advance development of fenoTRACK device
The funding round was led by Dexcom Ventures and saw contributions from CareSource Indiana and Elevate Ventures and others. MyBiometry has secured a $5m investment in an oversubscribed seed funding round to propel the development of its fenoTRACK device for... Read More →
Zetagen Therapeutics Announces First Patients Enrolled in Phase 2a Clinical Study of ZetaMet™ (Zeta-BC-003) Metastatic Breast Cancer
(400,000 patients annually are diagnosed with metastatic lytic bone lesions with only non-curative, palliative therapies available) ZetaMet™ (Zeta-BC-003) is a first-of-its kind molecular pathway designed to resolve metastatic cancer lesions, inhibit pain, and regenerate bone Phase 2a study examines the... Read More →
Histology in your hands: cross-modal imaging shows living skin in full color featuring Enspectra Health
A long-sought goal in dermatology is the development of an imaging modality with sufficient resolution and compositional detail to noninvasively display skin histology in vivo. Here, we describe a system that achieves this goal using cross-sectionally scanned, multimodal microscopy (cross-modal).... Read More →
Plio Surgical wins big at the InterTradeIreland start-up competition
The Trinity spin-out is looking to raise €3.6m to conduct its first clinical trials. Medical device developer Plio Surgical was announced as the overall winner at an all-island investor readiness competition, taking home €100,000. The annual InterTradeIreland all-island Seedcorn Investor... Read More →
MedTech Innovator at 10 featuring ExplORer Surgical, BardyDx, and Pathology Watch
Over the 10 years since Paul Grand created the medtech industry’s largest accelerator, it has helped start-ups launch many innovative medical products. We speak with the founders of ExplORer Surgical, BardyDx, and Pathology Watch about the role MedTech Innovator played... Read More →